Hints and tips:
...“The cycle can easily be 15 years from inception to commercial success,” said Fred Hassan, a director of Warburg Pincus’s health practice and a pharmaceuticals industry veteran....
...Hassan Rouhani calls on Europe to work with Iran to stand up to US unilateralism....
...CVC Capital Partners has hired Fred Hassan as chairman of the international women’s health assets that the private equity firm acquired from Teva Pharmaceutical earlier this year....
...MSMB’s investors included the daughter of Fred Hassan, former chief executive of drugmaker Schering Plough, according to the lawsuit....
...Fred Hassan, the former chief executive of Schering Plough, recently joined the board of Amgen, the investor pointed out....
...Hassan, the former chief executive of pharmaceuticals company Schering Plough....
...FT comment editor Fred Studemann discusses with Shashank Joshi from the Royal United Services Institute and James Blitz, the FT's defence and diplomatic editor, whether Iran's new president Hassan Rouhani...
...Among them were Michael Porter of Harvard; Mr Kim’s personal coach Marshall Goldsmith; Fred Hassan, another turnround artist at drug company Schering-Plough; former British prime minister Tony Blair; and...
...As part of the arrangement, Bausch & Lomb will retain its brand and division, and Valeant will bring on to its own board Fred Hassan, Bausch & Lomb’s chairman, and hire Dan Wechsler, head of its pharmaceuticals...
...In 2010, Warburg Pincus appointed one of its managing directors, Fred Hassan, the former chief executive of drugmaker Schering Plough, as chairman of Bausch & Lomb, and Brent Saunders, also a former Schering-Plough...
...In pharmaceuticals, Fred Hassan received $189m when Schering Plough was bought by Merck, and Hank McKinnell got $188m when he left Pfizer, despite an investor campaign under the slogan “give it back, Hank...
...Ms Jung, who was chief executive from 2001 until April, will be replaced as chairman by Fred Hassan, a current board member and former chief executive of Schering-Plough, the pharmaceutical group that merged...
...President Hassan Sheikh Mohamoud last week secured parliamentary approval for a slimline 10-member cabinet but risks remain....
...Fred Hassan, lead independent director, will succeed Ms Jung as non-executive chairman....
...After Coty raised its bid from $10bn to $10.7bn earlier this month, Coty chairman Bart Becht personally tried to reach Ms McCoy, Ms Jung and Fred Hassan, Avon’s lead independent director, according to people...
...Fred Hassan, the veteran Pakistan-born pharmaceuticals executive who most recently ran Schering-Plough until its sale to Merck last year, says: “When I started, you only talked about the markets of the US...
...“The changes in the macro-environment have transformed everything,” said Fred Hassan, head of Schering-Plough, earlier this year when explaining his agreement to the takeover by Merck....
...Last December, only weeks after Barack Obama had won the race for the US presidency, Richard Clark, the head of Merck, arranged a meeting with Fred Hassan, his opposite number at Schering-Plough....
...Fred Hassan, a chemical engineer who ran Schering- Plough of the US, will also cease to be a chief executive once Merck of the US – run by Richard Clark, who trained in liberal arts and business – completes...
...Fred Hassan, Schering-Plough chief, cited “good respect among the three companies” in response to analysts who grilled Merck and Schering over the issue when the deal was announced....
...Fred Hassan, chairman and chief executive, said that ”despite a tough environment and challenges to the US cholesterol joint venture products,” the company invested in research and development and paid down...
...Fred Hassan, head of Schering-Plough, which recently agreed a $48bn takeover by Merck, says: “We were in line with our strategic plan and doing well with good growth, but the changes in the macro-environment...
...In a conference call with investors, Schering’s chief executive and chairman, Fred Hassan, said the company’s strong stable of drugs in late-phase development would help supplement the “cholesterol challenge...
...His views were echoed by Fred Hassan, head of Schering Plough and president of the EFPIA’s international equivalent, who said regulators should also be more flexible in adjusting the “endpoints” by which...
...For Schering-Plough, the transaction marks the boldest step so far by Fred Hassan, chief executive since 2003, to rebuild a company struggling with numerous legal problems and investigations, as well as...
International Edition